3164.TW
Price:
$18.25
Market Cap:
$1.57B
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.
Industry
Biotechnology
IPO Date
2008-09-19
Stock Exchange
TAI
Ticker
3164.TW
According to GenMont Biotech Incorporation’s latest financial reports and current stock price. The company's current PE Ratio is 46.79. This represents a change of -6.85% compared to the average of 50.23 of the last 4 quarters.
The mean historical PE Ratio of GenMont Biotech Incorporation over the last ten years is 24.95. The current 46.79 PE Ratio has changed 18.66% with respect to the historical average. Over the past ten years (40 quarters), 3164.TW's PE Ratio was at its highest in in the December 2024 quarter at 208.83. The PE Ratio was at its lowest in in the June 2016 quarter at -1104.41.
Average
24.95
Median
31.34
Minimum
-21.99
Maximum
65.00
Discovering the peaks and valleys of GenMont Biotech Incorporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 257.03%
Maximum Annual PE Ratio = 65.00
Minimum Annual Increase = -606.40%
Minimum Annual PE Ratio = -21.99
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 30.52 | -53.04% |
| 2023 | 65.00 | 80.93% |
| 2022 | 35.93 | 93.28% |
| 2021 | 18.59 | -42.20% |
| 2020 | 32.16 | -16.56% |
| 2019 | 38.54 | 161.43% |
| 2018 | 14.74 | -67.13% |
| 2017 | 44.85 | -606.40% |
| 2016 | -8.86 | -59.74% |
| 2015 | -21.99 | 257.03% |
The current PE Ratio of GenMont Biotech Incorporation (3164.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
43.82
5-year avg
36.44
10-year avg
24.95
GenMont Biotech Incorporation’s PE Ratio is less than BiOptic Inc. (62.08), greater than Meribank Biotech Co., Ltd (-20.99), greater than NaviFUS Corp. (-11.77), greater than Enimmune corporation (-7.05), less than Abnova (Taiwan) Corporation (770.17), greater than GeneReach Biotechnology Corp. (-7.44), greater than Great Novel Therapeutics Biotech & Medicals (-17.32), greater than MegaPro Biomedical Co., Ltd (-5.28), greater than Bioptik Technology Incorporation (20.19), greater than Perfect Medical Industry Co., Ltd. (21.41),
| Company | PE Ratio | Market cap |
|---|---|---|
| 62.08 | $1.37B | |
| -20.99 | $1.53B | |
| -11.77 | $1.44B | |
| -7.05 | $1.48B | |
| 770.17 | $1.39B | |
| -7.44 | $1.12B | |
| -17.32 | $1.52B | |
| -5.28 | $958.26M | |
| 20.19 | $1.47B | |
| 21.41 | $1.59B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GenMont Biotech Incorporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GenMont Biotech Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GenMont Biotech Incorporation's PE Ratio?
How is the PE Ratio calculated for GenMont Biotech Incorporation (3164.TW)?
What is the highest PE Ratio for GenMont Biotech Incorporation (3164.TW)?
What is the 3-year average PE Ratio for GenMont Biotech Incorporation (3164.TW)?
What is the 5-year average PE Ratio for GenMont Biotech Incorporation (3164.TW)?
How does the current PE Ratio for GenMont Biotech Incorporation (3164.TW) compare to its historical average?